Real World Case 1 – 16 Y/O Male

A Translational Study 'Case Report' on the Small Molecule 'Energy Blocker' 3-Bromopyruvate (3BP) as a Potent Anticancer Agent: From Bench Side to Bedside(2012)
The first patient to be treated with Dr. Ko's 3BP compound.


  • Treated at Frankfurt University in 2009
  • 16yr old patient with progressive fibrolamellar hepatocellular carcinoma, 3 month of prognosis
  • The patient was given 9 doses of KAT (200 mg) over a period of 6 months
  • After treatment, the patient loses cancer and the tissue regenerates from 5% to 30%
  • 1.5years after CR, the patient dies of pneumonia due to excessive antibiotic therapy that destroyed liver function. No cancer was found as a result of CT scan by postmortem examination


  • Left images taken before treatment, right images taken after 9th treatment.
  • Tumors throughout liver (L) are necrotic, encapsulated, and showing fibrosis.
  • Lymph nodes that were enlarged (green star) have returned to stable size and shape.
  • Spleen size (S) that was enlarged has drastically reduced.